Enlivex Therapeutics Ltd. (ENLV) Granted Two US Patents Covering Methods of Treating Sepsis with Allocetra
Go back to Enlivex Therapeutics Ltd. (ENLV) Granted Two US Patents Covering Methods of Treating Sepsis with Allocetra| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 1.45 -0.05 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.50 | 52 Week High | $0.94 | |||
| Open | $1.45 | 52 Week Low | $0.47 | |||
| Day High | $1.51 | P/E | N/A | |||
| Day Low | $1.44 | EPS | $-0.11 | |||
| Volume | 52,788 | |||||
